Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Completed1
Not yet recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

completed133%
not_yet_recruiting133%
terminated133%

Recent Activity

0 active trials
Showing 3 of 3
not_yet_recruitingphase_1

Psilocybin for Treatment of OCD-2

NCT06992999
terminatedphase_1

Effects of Psilocybin in Concussion Headache

NCT03806985
completedphase_1

Psilocybin for the Treatment of Migraine Headache

NCT03341689

Clinical Trials (3)

Showing 3 of 3 trials
NCT06992999Phase 1

Psilocybin for Treatment of OCD-2

Not Yet Recruiting
NCT03806985Phase 1

Effects of Psilocybin in Concussion Headache

Terminated
NCT03341689Phase 1

Psilocybin for the Treatment of Migraine Headache

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3